InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Smith Karen L., Vice-Président Exécutif et Directeur Médical. Insider active across 6 companies, notably Emergent BioSolutions Inc.. In total, 12 disclosures have been logged. History available since 7 May 2021. The latest transaction was filed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Smith Karen L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
25,000 股0Common StockSEC:0001415889-25-017374:0
12,135 股0Common SharesSEC:0001600620-24-000126:0
17,913 股Common StockSEC:0001600620-24-000114:0
25,000 股0Common StockSEC:0001415889-24-015762:0
13,900 股0Common StockSEC:0001209191-23-034407:0
170,354 股0Common StockSEC:0001209191-22-032677:0
54,193 股@ US$5.6060.5% 占其流量Common StockSEC:0000899243-22-019793:0
24,336 股Common StockSEC:0001209191-22-031508:0
12,500 股0Common StockSEC:0001209191-22-014157:0
1,622 股Common StockSEC:0001104659-21-142277:0
25,452 股@ US$4.4224.6% 占其流量Common StockSEC:0001209191-21-040340:0
305 股@ US$60.85100.0% 占其流量Common StockSEC:0001367644-21-000081:0
12 条申报中的 12 条
About Smith Karen L.
Karen L. Smith is EVP, Chief Medical Officer at Emergent BioSolutions Inc., Antares Pharma, Inc., and Acceleron Pharma Inc. She oversees medical and strategic initiatives, playing a key role in product development and innovation.
